BRCA1 Antibodies

Santa Cruz Biotechnology provides a broad selection of BRCA1 monoclonal antibodies for research focused on understanding BRCA1's role in cellular processes. BRCA1 monoclonal antibodies are applicable in various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRCA1 is a key protein involved in the repair of DNA double-strand breaks, playing a vital role in maintaining genomic stability. Mutations in the BRCA1 gene are associated with an increased risk of breast and ovarian cancers, making it an important target for cancer research and therapeutic development. Understanding the function and regulation of BRCA1 is essential for advancing knowledge of tumorigenesis and improving cancer treatment strategies. BRCA1 monoclonal antibodies enable researchers to investigate protein-protein interactions and cellular localization patterns. BRCA1 monoclonal antibodies support studies examining DNA damage response pathways and cell cycle regulation. BRCA1 research continues to reveal new insights into cancer development and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific understanding of BRCA1's role in cancer biology and therapeutic development.